AEON Biopharma, Inc.
AEON
$0.24
$0.000.60%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.72M | 12.99M | 12.21M | 11.35M | 12.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.90M | 18.29M | 16.30M | 16.87M | 17.95M |
| Operating Income | -19.90M | -18.29M | -16.30M | -16.87M | -17.95M |
| Income Before Tax | -54.62M | -60.11M | -39.22M | -3.00K | -1.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.62 | -60.11 | -39.22 | 0.00 | -1.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.62M | -60.11M | -39.22M | -3.00K | -1.64M |
| EBIT | -19.90M | -18.29M | -16.30M | -16.87M | -17.95M |
| EBITDA | -19.82M | -18.21M | -16.23M | -16.79M | -17.87M |
| EPS Basic | -3.58 | -4.16 | -1.59 | 5.05 | -5.80 |
| Normalized Basic EPS | -1.15 | -1.41 | -0.23 | -4.65 | -9.37 |
| EPS Diluted | -3.58 | -4.16 | -1.59 | 5.04 | -5.82 |
| Normalized Diluted EPS | -1.15 | -1.41 | -0.23 | -4.64 | -9.36 |
| Average Basic Shares Outstanding | 115.67M | 76.23M | 39.60M | 27.26M | 16.18M |
| Average Diluted Shares Outstanding | 115.67M | 76.23M | 39.60M | 27.27M | 16.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |